August 29, 2023
iocto supports team of TU Darmstadt
As a family-owned business, supporting young talents in the best possible way is important to us. We are currently supporting a research project of the TU Darmstadt for the international SensUs competition in Eindhoven: The students of the team TUcanSense are developing biosensors that will be used in the medical field.
Last Friday, our CEO Stefan Schmitt and project manager Paul Schumacher visited the students at the IDD (Institute of Printing Science and Technology) in Darmstadt and handed them a 2,500 euros check. During the following talk, Stefan Schmitt emphasized that supporting the team is a great way to further advance innovative ideas: “We at iocto are developing future technologies ourselves and believe in the great potential of biosensing. That’s why we are excited to support students in developing new solutions that can help people around the world.“
How biosensor technology enriches everyday life
Biosensors are based on the idea of using biological reactions to measure diverse parameters. They are used in a wide variety of sectors, such as medical diagnostics (e.g. for the early detection of diseases), environmental monitoring (e.g. for checking water quality), or in the food industry (e.g. for the detection of toxins or allergens).
SensUs: A global student competition
SensUs is an international, interdisciplinary competition organized by Eindhoven University of Technology (Netherlands) in which multidisciplinary teams from different universities compete against each other to come up with solutions to medical challenges. The task in 2023 is the development of biosensors to identify craniocerebral trauma.
Accordingly, the Darmstadt team is also taking up this challenge and developing a solution approach using printed elements as part of their project.
We are very happy about the partnership with of the Technical University of Darmstadt and wish the team TUcanSense good luck and all the best in Eindhoven!
As the TUcanSense team explained to us, the focus of their project is on the detection of the protein GFAP, which can be used as a biomarker for craniocerebral trauma. Using printed electrodes and an aptamer antibody sandwich, the students detect the concentration of GFAP in blood plasma. This could optimize the treatment of patients through rapid and targeted diagnosis.